CEO Dr Hilja Ibert joins BioTalk podcast | Gentian US, Inc.
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
post-template-default,single,single-post,postid-20137,single-format-standard,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Gentian’s CEO Dr Hilja Ibert @ BIOTALK podcast

Biotalk - BioHealth Innovation podcast with Gentian CEO Hilja Ibert

Gentian’s CEO Dr Hilja Ibert @ BIOTALK podcast

POdcast: CEO Dr Hilja Ibert at BioTalk

Gentian’s CEO Dr Hilja Ibert, PhD, joined BioTalk host Rich Bendis, Founder, President and CEO BioHealth Innovation Inc. at the Capital Region Investor Conference last week. In this podcast Dr Ibert talks about Gentian’s presence in the US market, biomarkers and how Gentian focuses on innovating diagnostic efficiency.

Listen to the podcast now

recording BioTalks - BioHealth Innvovation podcast with Gentian CEO

BioHealth Innovation and Gentian

Gentian’s subsidiary in the US, Gentian USA, Inc. collaborates with BioHealth Innovation (BHI) in order to expand Gentian’s presence in the USA. BHI is an innovation intermediary that translates relevant market research into commercial success by connecting management, funding, and markets. The collaboration allows Gentian to support current and new US customers and OEM partners more closely, and will also make Gentian’s products more visible to a larger US customer base.


Want to know more about our company and our immunoassays? Fill out the form below and our US Product Specialist will help you..

Contact Us - USA
We innovate diagnostic efficiency